The tumor suppressor p16 (INK4A/MTS-1/CDKN2A) has gained widespread importance in cancer research, because the loss of p16 is described as an early event in cancer progression [59]; however, its induction is strongly associated with the induction of senescence [60]. This evidence concerns the gene CDKN2A and cancer.